BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 38456510)

  • 1. High-mobility group box 1 increases platelet surface P2Y12 and platelet activation in sickle cell disease.
    Nolfi-Donegan D; Annarapu GK; St Croix C; Calderon M; Hillery CA; Shiva S
    JCI Insight; 2024 Mar; 9(5):. PubMed ID: 38456510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of prasugrel on ADP-stimulated markers of platelet activation in patients with sickle cell disease.
    Jakubowski JA; Zhou C; Winters KJ; Lachno DR; Howard J; Payne CD; Mant T; Jurcevic S; Frelinger AL
    Platelets; 2015; 26(5):474-9. PubMed ID: 25140584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet-derived HMGB1 is a critical mediator of thrombosis.
    Vogel S; Bodenstein R; Chen Q; Feil S; Feil R; Rheinlaender J; Schäffer TE; Bohn E; Frick JS; Borst O; Münzer P; Walker B; Markel J; Csanyi G; Pagano PJ; Loughran P; Jessup ME; Watkins SC; Bullock GC; Sperry JL; Zuckerbraun BS; Billiar TR; Lotze MT; Gawaz M; Neal MD
    J Clin Invest; 2015 Dec; 125(12):4638-54. PubMed ID: 26551681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The platelet NLRP3 inflammasome is upregulated in sickle cell disease via HMGB1/TLR4 and Bruton tyrosine kinase.
    Vogel S; Arora T; Wang X; Mendelsohn L; Nichols J; Allen D; Shet AS; Combs CA; Quezado ZMN; Thein SL
    Blood Adv; 2018 Oct; 2(20):2672-2680. PubMed ID: 30333099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sickle cell disease increases high mobility group box 1: a novel mechanism of inflammation.
    Xu H; Wandersee NJ; Guo Y; Jones DW; Holzhauer SL; Hanson MS; Machogu E; Brousseau DC; Hogg N; Densmore JC; Kaul S; Hillery CA; Pritchard KA
    Blood; 2014 Dec; 124(26):3978-81. PubMed ID: 25339362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet activation biomarkers in Berkeley sickle cell mice and the response to prasugrel.
    Ohno K; Tanaka H; Samata N; Jakubowski JA; Tomizawa A; Mizuno M; Sugidachi A
    Thromb Res; 2014 Oct; 134(4):889-94. PubMed ID: 25130912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory Effect of Flavonolignans on the P2Y12 Pathway in Blood Platelets.
    Bijak M; Szelenberger R; Dziedzic A; Saluk-Bijak J
    Molecules; 2018 Feb; 23(2):. PubMed ID: 29439388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipopolysaccharide-Activated Canine Platelets Upregulate High Mobility Group Box-1 via Toll-Like Receptor 4.
    Li RHL; Hommel C; Nguyen N
    Front Vet Sci; 2021; 8():674678. PubMed ID: 34235204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet activation and inhibition in sickle cell disease (pains) study.
    Frelinger AL; Jakubowski JA; Brooks JK; Carmichael SL; Berny-Lang MA; Barnard MR; Heeney MM; Michelson AD
    Platelets; 2014; 25(1):27-35. PubMed ID: 23469943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HMGB1: a novel protein that induced platelets active and aggregation via Toll-like receptor-4, NF-κB and cGMP dependent mechanisms.
    Yang X; Wang H; Zhang M; Liu J; Lv B; Chen F
    Diagn Pathol; 2015 Aug; 10():134. PubMed ID: 26245198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid rafts are required in Galpha(i) signaling downstream of the P2Y12 receptor during ADP-mediated platelet activation.
    Quinton TM; Kim S; Jin J; Kunapuli SP
    J Thromb Haemost; 2005 May; 3(5):1036-41. PubMed ID: 15869601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of ADP receptors in platelet function.
    Murugappa S; Kunapuli SP
    Front Biosci; 2006 May; 11():1977-86. PubMed ID: 16368572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell Surface Platelet Tissue Factor Expression: Regulation by P2Y
    Brambilla M; Becchetti A; Rovati GE; Cosentino N; Conti M; Canzano P; Giesen PLA; Loffreda A; Bonomi A; Cattaneo M; De Candia E; Podda GM; Trabattoni D; Werba PJ; Campodonico J; Pinna C; Marenzi G; Tremoli E; Camera M
    Arterioscler Thromb Vasc Biol; 2023 Oct; 43(10):2042-2057. PubMed ID: 37589138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HMGB1 binds to activated platelets via the receptor for advanced glycation end products and is present in platelet rich human coronary artery thrombi.
    Ahrens I; Chen YC; Topcic D; Bode M; Haenel D; Hagemeyer CE; Seeba H; Duerschmied D; Bassler N; Jandeleit-Dahm KA; Sweet MJ; Agrotis A; Bobik A; Peter K
    Thromb Haemost; 2015 Nov; 114(5):994-1003. PubMed ID: 26202300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase 1 study of prasugrel in patients with sickle cell disease: effects on biomarkers of platelet activation and coagulation.
    Jakubowski JA; Zhou C; Jurcevic S; Winters KJ; Lachno DR; Frelinger AL; Gupta N; Howard J; Payne CD; Mant TG
    Thromb Res; 2014 Feb; 133(2):190-5. PubMed ID: 24368019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toll-like receptor expression and functional behavior in platelets from patients with systemic lupus erythematosus.
    Baroni Pietto MC; Glembotsky AC; Lev PR; Marín Oyarzún CR; De Luca G; Gomez G; Collado MV; Charó N; Cellucci AS; Heller PG; Goette NP; Marta RF
    Immunobiology; 2024 Jan; 229(1):152782. PubMed ID: 38159527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NOD2-mediated P2Y
    Zhong H; Waresi M; Zhang W; Han L; Zhao Y; Chen Y; Zhou P; Chang L; Pan G; Wu B; Li J; Zhang S; Shi H; Luo X; Gao W; Qi Z; Ding Z
    Biochem Pharmacol; 2021 Dec; 194():114822. PubMed ID: 34748820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disulfide HMGB1 derived from platelets coordinates venous thrombosis in mice.
    Stark K; Philippi V; Stockhausen S; Busse J; Antonelli A; Miller M; Schubert I; Hoseinpour P; Chandraratne S; von Brühl ML; Gaertner F; Lorenz M; Agresti A; Coletti R; Antoine DJ; Heermann R; Jung K; Reese S; Laitinen I; Schwaiger M; Walch A; Sperandio M; Nawroth PP; Reinhardt C; Jäckel S; Bianchi ME; Massberg S
    Blood; 2016 Nov; 128(20):2435-2449. PubMed ID: 27574188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GRK2 regulates ADP signaling in platelets via P2Y1 and P2Y12.
    Zhao X; Cooper M; Michael JV; Yarman Y; Baltz A; Chuprun JK; Koch WJ; McKenzie SE; Tomaiuolo M; Stalker TJ; Zhu L; Ma P
    Blood Adv; 2022 Aug; 6(15):4524-4536. PubMed ID: 35793439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring platelet inhibition after clopidogrel with the VerifyNow-P2Y12(R) rapid analyzer: the VERIfy Thrombosis risk ASsessment (VERITAS) study.
    Malinin A; Pokov A; Spergling M; Defranco A; Schwartz K; Schwartz D; Mahmud E; Atar D; Serebruany V
    Thromb Res; 2007; 119(3):277-84. PubMed ID: 16563469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.